ArticlePLoS pathogens2018

Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.

Chadi Zakaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.